Twitter

Archive for October 31st, 2011


Study With a Sequential Clofarabine-cyclophosphamide Combination Schedule as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults

Condition :   Acute Lymphoblastic Leukemia Intervention :   Drug: Clofarabine, Cyclophosphamide Sponsor :   Gruppo Italiano Malattie EMatologiche dell’Adulto Not yet recruiting – verified October 2011

Read More...

Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma

Condition :   Melanoma Interventions :   Drug: Bortezomib;   Drug: Interferon Alfa-2b Sponsor :   Ohio State University Comprehensive Cancer Center Active, not recruiting – verified October 2011

Read More...

Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma

Condition :   Locally Advanced Nasopharyngeal Carcinoma Interventions :   Drug: Famitinib;   Drug: Cisplatin;   Radiation: radiation Sponsors :   Jiangsu HengRui Medicine Co., Ltd.;   Sun Yat-sen University Recruiting – verified October 2011

Read More...

Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors

Condition :   Neuroblastoma Intervention :   Device: CD34+ cells selected with the Miltenyi Clinimacs machine Sponsors :   Children’s Mercy Hospital Kansas City;   University of Kansas Recruiting – verified October 2011

Read More...

L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases

Conditions :   Colon Carcinoma;   Rectum Carcinoma Interventions :   Biological: L-BLP25;   Biological: Placebo Sponsor :   Dr. Carl Schimanski Recruiting – verified October 2011

Read More...

Immune Therapy of HPV-induced Cancers

Condition :   HPV-induced Cancers Intervention :   Biological: P16_37-63 Sponsor :   Oryx GmbH & Co. KG Recruiting – verified October 2011

Read More...

Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer

Condition :   Advanced Ovarian Cancer Interventions :   Drug: Neoadjuvant chemotherapy;   Drug: Carboplatin Sponsors :   Asan Medical Center;   Sanofi-Aventis Recruiting – verified October 2011

Read More...

Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma

Condition :   Angiosarcoma Intervention :   Drug: Pazopanib Sponsors :   Fox Chase Cancer Center;   National Comprehensive Cancer Network;   GlaxoSmithKline Recruiting – verified October 2011

Read More...

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Condition :   Brain and Central Nervous System Tumors Interventions :   Drug: sunitinib malate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study Sponsors :   Children’s Oncology Group;   National Cancer Institute (NCI) Not yet recruiting – verified October 2011

Read More...

The Role of the EKG in Anticancer Drug Development

Condition :   Advanced Cancer Intervention :   Sponsor :   M.D. Anderson Cancer Center Recruiting – verified October 2011

Read More...